DK131466B - Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf. - Google Patents

Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf.

Info

Publication number
DK131466B
DK131466B DK184372AA DK184372A DK131466B DK 131466 B DK131466 B DK 131466B DK 184372A A DK184372A A DK 184372AA DK 184372 A DK184372 A DK 184372A DK 131466 B DK131466 B DK 131466B
Authority
DK
Denmark
Prior art keywords
triethoxybenzyl
diamino
pyrimidine
salts
preparation
Prior art date
Application number
DK184372AA
Other languages
English (en)
Other versions
DK131466C (da
Inventor
B Roth
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK131466B publication Critical patent/DK131466B/da
Application granted granted Critical
Publication of DK131466C publication Critical patent/DK131466C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK184372AA 1971-04-16 1972-04-14 Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf. DK131466B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (2)

Publication Number Publication Date
DK131466B true DK131466B (da) 1975-07-21
DK131466C DK131466C (da) 1975-12-08

Family

ID=9875880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK184372AA DK131466B (da) 1971-04-16 1972-04-14 Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf.

Country Status (13)

Country Link
JP (3) JPS5320511B1 (da)
AU (1) AU468447B2 (da)
BE (1) BE782153A (da)
CA (1) CA967964A (da)
CH (1) CH565160A5 (da)
CS (1) CS181221B2 (da)
DE (1) DE2218220A1 (da)
DK (1) DK131466B (da)
FR (1) FR2133752B1 (da)
GB (1) GB1407971A (da)
IL (3) IL39218A (da)
NL (1) NL7205043A (da)
SE (1) SE391180B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (fr) * 1953-03-11 1955-03-30 Wellcome Found Dérivés de pyrimidine et leur fabrication
FR1459417A (fr) * 1964-11-12 1966-04-29 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
FR1518635A (fr) * 1965-07-08 1968-03-29 Wellcome Found Procédé de préparation de dérivés de la pyrimidine
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles

Also Published As

Publication number Publication date
CH565160A5 (da) 1975-08-15
CS181221B2 (en) 1978-03-31
IL47921A0 (en) 1975-11-25
GB1407971A (en) 1975-10-01
IL39218A (en) 1976-10-31
JPS5422994B2 (da) 1979-08-10
DE2218220A1 (de) 1972-11-02
JPS5320511B1 (da) 1978-06-27
NL7205043A (da) 1972-10-18
AU4117472A (en) 1973-10-18
JPS5430189A (en) 1979-03-06
IL47921A (en) 1976-10-31
JPS53111083A (en) 1978-09-28
DK131466C (da) 1975-12-08
FR2133752A1 (da) 1972-12-01
IL39218A0 (en) 1972-06-28
FR2133752B1 (da) 1975-04-25
BE782153A (fr) 1972-10-16
CA967964A (en) 1975-05-20
AU468447B2 (en) 1976-01-15
SE391180B (sv) 1977-02-07

Similar Documents

Publication Publication Date Title
DK125709B (da) Analogifremgangsmåde til fremstilling af serumlipidsænkende 3,5-substituerede pyridinderivater eller salte deraf.
DK132172B (da) Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf.
DK129650B (da) Analogifremgangsmåde til fremstilling af 1-phenoxy-2-hydroxy-3-amino-propaner eller salte deraf.
DK136060B (da) Analogifremgangsmåde til fremstilling af 3-substituerede 1,4,5,6-tetrahydropyridiner eller salte deraf.
DK128078B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater eller salte deraf.
DK130681B (da) Analogifremgangsmåde til fremstilling af 5-ætyl-2,3,5,8-tetrahydro-8-okso-furo-[2,3-g]-kinolin-7-karboksylsyre eller salte deraf.
DK137382B (da) Analogifremgangsmåde til fremstilling af 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidin)butyramider eller syreadditionssalte deraf.
DK131721B (da) Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf.
DK132275B (da) Analogifremgangsmåde til fremstilling af antiviralt aktive 2,7-bis-(tert.aminoalkanoyl)-xanthener eller -xanthen-9-oner eller syreadditionssalte deraf.
DK135534B (da) Fremgangsmåde til fremstilling af pyrasol-(3,4-d)-pyrimidiner eller salte heraf.
DK139388B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-7,7-dimethyl-7,8-dihydropteridiner eller tautomere heraf eller salte af disse forbindelser.
DK138797B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepin-derivater eller N-oxider eller salte deraf.
DK128496B (da) Fremgangsmåde til fremstilling af 5-fluoruracilderivater.
DK137758B (da) Analogifremgangsmåde til fremstilling af 2-(5-nitro-2-imidazolyl)-benzimidazoler eller salte deraf.
DK131466B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf.
DK116285B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-6-(substitueret nitrosamino)-quinazolin-forbindelser eller salte deraf.
DK126946B (da) Analogifremgangsmåde til fremstilling af 6-morpholino-4-oxo-4,5-dihydro-isothiazolo[5,4-d] pyrimidinderivater eller salte deraf.
DK127424B (da) Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf.
DK135504B (da) Analogifremgangsmåde til fremstilling af 6-substituerede 3-carbethoxyhydrazinopyridaziner eller salte deraf.
DK131374B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.
DK137044B (da) Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf.
DK126996B (da) Analogifremgangsmåde til fremstilling af 5-ethyl-5-(m-carbethoxyaminophenyl)-malonylurinstof eller salte deraf.
DK120706B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidin.
DK135375B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxy-5-(3',4',5'-trimetoxybenzyl)-pyrimidin.
DK121955B (da) Analogifremgangsmåde til fremstilling af 1,4-substituerede phenylpiperaziner eller syreadditionssalte deraf.